Boston Scientific buy Royal Bank of Canada
Start price
16.01.24
/
50%
€55.40
Target price
16.01.25
€61.53
Performance (%)
21.84%
Price
30.04.24
€67.50
Summary
This prediction is currently active. The prediction currently has a performance of 21.84%. This prediction currently runs until 16.01.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Boston Scientific | 4.651% | 4.651% |
iShares Core DAX® | -1.370% | -3.231% |
iShares Nasdaq 100 | 0.172% | -3.339% |
iShares Nikkei 225® | -0.801% | -7.859% |
iShares S&P 500 | -0.369% | -2.979% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Boston Scientific diskutieren
Boston Scientific Co. (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $67.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Boston Scientific
Boston Scientific
Start price
Target price
Perf. (%)
€68.00
25.04.24
25.04.24
€76.49
25.04.25
25.04.25
-0.74%
30.04.24
30.04.24
Boston Scientific
Start price
Target price
Perf. (%)
€59.08
01.02.24
01.02.24
€64.55
01.02.25
01.02.25
14.25%
30.04.24
30.04.24
Boston Scientific
Start price
Target price
Perf. (%)
€50.76
21.09.23
21.09.23
€57.21
21.09.24
21.09.24
32.98%
30.04.24
30.04.24
Boston Scientific
Start price
Target price
Perf. (%)
€49.73
28.08.23
28.08.23
€53.66
28.08.24
28.08.24
35.73%
30.04.24
30.04.24